Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding two more study numbers and indicating that the study now has 72 locations, while the previous version 2.9.7 has been removed.
    Difference
    0.2%
    Check dated 2024-07-23T14:00:42.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T06:11:04.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Summary
    A new study on Semaglutide once weekly as an add-on to SGLT-2 inhibitor therapy in type 2 diabetes was published in Lancet Diabetes Endocrinology in May 2019, with subsequent errata and updates in August and November 2019.
    Difference
    0.2%
    Check dated 2024-07-08T22:46:35.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-07-02T13:32:56.000Z thumbnail image
  9. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has changed from v2.9.3 to v2.9.5, indicating an update or modification to the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-27T09:31:38.000Z thumbnail image
  10. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-26T08:29:26.000Z thumbnail image

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.